These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Role of BP230 autoantibodies in bullous pemphigoid. Shih YC, Wang B, Yuan H, Zheng J, Pan M. J Dermatol; 2020 Apr; 47(4):317-326. PubMed ID: 32048350 [Abstract] [Full Text] [Related]
13. Normal human skin is superior to monkey oesophagus substrate for detection of circulating BP180-NC16A-specific IgG antibodies in bullous pemphigoid. Emtenani S, Yuan H, Lin C, Pan M, Hundt JE, Schmidt E, Komorowski L, Stanley JR, Hammers CM. Br J Dermatol; 2019 May; 180(5):1099-1106. PubMed ID: 30315657 [Abstract] [Full Text] [Related]
14. IgG antibodies against immunodominant C-terminal epitopes of BP230 do not induce skin blistering in mice. Feldrihan V, Licarete E, Florea F, Cristea V, Popescu O, Sitaru C, Chiriac MT. Hum Immunol; 2014 Apr; 75(4):354-63. PubMed ID: 24468586 [Abstract] [Full Text] [Related]
15. Bullous pemphigoid antigen II (BP180) and its soluble extracellular domains are major autoantigens in mucous membrane pemphigoid: the pathogenic relevance to HLA class II alleles and disease severity. Oyama N, Setterfield JF, Powell AM, Sakuma-Oyama Y, Albert S, Bhogal BS, Vaughan RW, Kaneko F, Challacombe SJ, Black MM. Br J Dermatol; 2006 Jan; 154(1):90-8. PubMed ID: 16403100 [Abstract] [Full Text] [Related]
16. Bullous pemphigoid (BP) patients with selective IgG autoreactivity against BP230: Review of a rare but valuable cohort with impact on the comprehension of the pathogenesis of BP. Ramcke T, Vicari E, Bolduan V, Enk A, Hadaschik E. J Dermatol Sci; 2022 Feb; 105(2):72-79. PubMed ID: 34930674 [Abstract] [Full Text] [Related]